Selective and rapid uptake of adeno-associated virus type 2 in brain

Human Gene Therapy

Volumn 9, Issue 8, 1998, Pages 1181-1186

  Bartlett, Jeffrey S ^a   Samulski, R Jude ^a   McCown, Thomas J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN INFECTION; GENE TRANSFER; HIPPOCAMPUS; INFERIOR COLLICULUS; KINETICS; NONHUMAN; OLIGODENDROGLIA; PLANT GROWTH; PROMOTER REGION; RAT; VIRUS CAPSID; VIRUS RECOMBINANT; VIRUS TRANSMISSION;

ADENO-ASSOCIATED VIRUS; ADENO-ASSOCIATED VIRUS 2; ANIMALIA; CUCUMBER MOSAIC VIRUS; DNA VIRUSES; HIPPOCAMPUS HIPPOCAMPUS; MIRIDAE;

EID: 0032550793     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.8-1181     Document Type: Article

References (9)

1. ALEXANDER, I.E., RUSSELL, D.W., and MILLER, A.D. (1994). DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors. J. Virol. 68, 8282-8287.
2. DOLL, R.F., CRANDALL, J.E., DYER, C.A., AUCOIN, J.M., and SMITH, F.I. (1996). Comparison of promoter strengths on gene delivery into mammalian brain cells using AAV vectors. Gene Ther. 3, 437-447.
3. FERRARI, F.K., SAMULSKI, T., SHENK, T., and SAMULSKI, R.J. (1996). Second-strand synthesis is a rate limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70, 3227-3234.
4. FISHER, K.J., GAO, G., WEITZMAN, M.D., DEMATTEO, R., BURDA, J.F., and WILSON, J.M. (1996). Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 70, 520-532.
5. GREWAL, R.P., YOSHIDA, T., FINCH, C.E., and MORGAN, T.E. (1997). Scavenger receptor mRNAs in rat brain microglia are induced by kainic acid lesioning and by cytokines. Neuroreport 8, 1077-1081.
6. JIN, B.K., BELLONI, M., CONTI, B., FEDEROFF, H.J., STARR, R., SON, J.H., BAKER, H., and JOH, T.H. (1996). Prolonged in vivo gene expression driven by a tyrosine hydroxylase promoter in a defective herpes simplex virus amplicon vector. Hum. Gene Ther. 7, 2015-2024.
7. RUSSELL, D.W., MILLER, A.D., and ALEXANDER, I.E. (1995). DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors. Proc. Natl. Acad. Sci. U.S.A. 92, 5719-5723.
8. SAMULSKI, R.J., CHANG, L.-S., and SHENK, T. (1989). Helper-free stocks of recombinant adeno-associated viruses: Normal integration does not require viral gene expression. J. Virol. 63, 3822-3828.
9. 1 containing receptors and increases inferior collicular seizure sensitivity. Brain Res. 756, 76-83.